Aster Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,862
Closed -$529K 1100
2025
Q1
$529K Buy
23,862
+23,544
+7,404% +$507K 0.1% 278
2024
Q4
$6.81K Buy
+318
New +$7.73K ﹤0.01% 823

Other funds holding CDNA

Aster Capital Management's CDNA Position: Q2 2025 in Review

Aster Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 23,862 shares — an estimated $529K sold.

Aster Capital Management first reported a position in CDNA in Q4 2024 and held it in 2 quarters. The position peaked at $529K in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Aster Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Aster Capital Management sold 23,862 CareDx shares in Q2 2025, an estimated $529K.
  • Aster Capital Management first reported a position in CareDx in Q4 2024 and held it in 2 quarters.
  • Aster Capital Management's CareDx position peaked at $529K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.